TrialScientific reports2020

A prospective cohort study on effects of gemigliptin on cardiovascular outcomes in patients with type 2 diabetes (OPTIMUS study).

Eun Heui Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.